We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Most malignancies were weakly stained or negative. Moderate cytoplasmic positivity was observed in renal cancers and several cases of breast, prostate, skin and pancreatic cancers.
Q9UJG1 [Direct mapping] Motile sperm domain-containing protein 1
Show all
Predicted membrane proteins Prediction method-based Membrane proteins predicted by MDM MEMSAT3 predicted membrane proteins MEMSAT-SVM predicted membrane proteins Phobius predicted membrane proteins SCAMPI predicted membrane proteins SPOCTOPUS predicted membrane proteins THUMBUP predicted membrane proteins TMHMM predicted membrane proteins # TM segments-based 2TM proteins predicted by MDM Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0005634 [nucleus] GO:0005737 [cytoplasm] GO:0016021 [integral component of membrane] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0048471 [perinuclear region of cytoplasm]
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0005634 [nucleus] GO:0005737 [cytoplasm] GO:0016021 [integral component of membrane] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0048471 [perinuclear region of cytoplasm]
Q9UJG1 [Direct mapping] Motile sperm domain-containing protein 1
Show all
Predicted intracellular proteins Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000122 [negative regulation of transcription from RNA polymerase II promoter] GO:0005634 [nucleus] GO:0005737 [cytoplasm] GO:0016021 [integral component of membrane] GO:0045944 [positive regulation of transcription from RNA polymerase II promoter] GO:0048471 [perinuclear region of cytoplasm]